Learn how to protect biological drug innovations during this webinar from Stockholm Science City (In Swedish). Ulrika Munter and Nora Spjuth share their experiences working with intellectual property in this field and Linus Plym Forshell from the Swedish Intellectual Property Office (PRV) provides an overview of IP strategies in the pharmaceutical sector. This webinar is in Swedish.
Protecting Biological Drug Innovations
You may also be interested in:
Navigating Meta’s shifted Moderation Model: What brand owners should prepare for
Meta is shifting away from third-party fact-checking and adopting the Community Notes Model, first introduced by X (formerly Twitter) under Elon Musk’s
Companies with IP generate at least 23.8% more revenue according to latest EU report
The report ‘The Intellectual Property Rights and Firm Performance in the European Union’ was published last month and analyses
European Commission reports show misuse of divisionals can in itself contravene EU law
In November last year, I was interviewed about the European Commission’s €462.6 million fine against pharmaceutical giant Teva and